Iveric Bio is a biopharmaceutical company that specializes in the development of innovative treatment options for diseases affecting the retina. Their focus is on age-related retinal diseases and inherited retinal diseases that currently have unmet medical needs. The company is committed to its mission of improving vision through cutting-edge therapies, including both therapeutic and gene therapy product candidates.
IVERIC bio's ticker is ISEE
The company's shares trade on the NASDAQ stock exchange
They are based in New York City, New York
There are 11-50 employees working at IVERIC bio
It is ivericbio.com
IVERIC bio is in the Healthcare sector
IVERIC bio is in the Biotechnology industry
The following five companies are IVERIC bio's industry peers: